CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy

被引:3
|
作者
Ko, Ji Su [1 ,2 ]
Lee, Jeong Hyun [1 ,2 ,4 ,5 ]
Yoon, Dok Hyun [3 ]
Suh, Chong Hyun [1 ,2 ]
Chung, Sae Rom [1 ,2 ]
Choi, Young Jun [1 ,2 ]
Baek, Jung Hwan [1 ,2 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea
[3] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[4] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[5] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
关键词
Acute lymphoblastic leukemia; Adoptive immunotherapy; Chimeric antigen receptor (CAR) T cells; CAR-T cell associated side effects; Cytokine-release syndrome; MANAGEMENT;
D O I
10.3348/kjr.2023.1100
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:399 / 402
页数:4
相关论文
共 50 条
  • [41] Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy?
    Lai, Xun
    Sun, Yun Yan
    Chang, Lung Ji
    Ma, Yu Ru
    Gu, Xue Zhong
    Yao, Xiang Mei
    Nie, Bo
    Wen, Yan
    Zhang, Xue Mei
    Jiang, Ya Xian
    Yang, Hui
    Yu, Li Qun
    Fang, Ming Jing
    Wang, Ling
    Bo, Xue Yuan
    BIOENGINEERED, 2020, 11 (01) : 824 - 828
  • [42] Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy
    Hong, Ruimin
    Zhao, Houli
    Wang, Yiyun
    Chen, Yu
    Cai, Hongliu
    Hu, Yongxian
    Wei, Guoqing
    Huang, He
    BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 570 - 580
  • [43] A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)-associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapy
    Zu, Cheng
    Wu, Shenghao
    Zhang, Mingming
    Wei, Guoqing
    Xu, Huijun
    Cui, Jiazhen
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    CYTOTHERAPY, 2023, 25 (11) : 1167 - 1175
  • [44] FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
    Le, Robert Q.
    Li, Liang
    Yuan, Weishi
    Shord, Stacy S.
    Nie, Lei
    Habtemariam, Bahru A.
    Przepiorka, Donna
    Farrell, Ann T.
    Pazdur, Richard
    ONCOLOGIST, 2018, 23 (08) : 943 - 947
  • [45] Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
    Barata, Anna
    Hoogland, Aasha, I
    Kommalapati, Anuhya
    Logue, Jennifer
    Welniak, Taylor
    Hyland, Kelly A.
    Eisel, Sarah L.
    Small, Brent J.
    Jayani, Reena, V
    Booth-Jones, Margaret
    Oswald, Laura B.
    Gonzalez, Brian D.
    Kirtane, Kedar S.
    Jain, Michael D.
    Mokhtari, Sepideh
    Chavez, Julio C.
    Lazaryan, Aleksandr
    Shah, Bijal D.
    Locke, Frederick L.
    Jim, Heather S. L.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 401.e1 - 401.e7
  • [46] Cognition following chimeric antigen receptor T-cell therapy: A systematic review
    Kazzi, Christina
    Kuznetsova, Valeriya
    Siriratnam, Pakeeran
    Griffith, Sarah
    Wong, Shu
    Tam, Constantine S.
    Alpitsis, Rubina
    Spencer, Andrew
    O'Brien, Terence J.
    Malpas, Charles B.
    Monif, Mastura
    JOURNAL OF AUTOIMMUNITY, 2023, 140
  • [47] Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model
    Nakamura, Naokazu
    Jo, Tomoyasu
    Arai, Yasuyuki
    Kitawaki, Toshio
    Nishikori, Momoko
    Mizumoto, Chisaki
    Kanda, Junya
    Yamashita, Kouhei
    Nagao, Miki
    Takaori-Kondo, Akifumi
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 404 - 414
  • [48] Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective
    Luan, Chengxin
    Zhou, Junjie
    Wang, Haixia
    Ma, Xiaoyu
    Long, Zhangbiao
    Cheng, Xin
    Chen, Xiaowen
    Huang, Zhenqi
    Zhang, Dagan
    Xia, Ruixiang
    Ge, Jian
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Myeloid cell and cytokine interactions with chimeric antigen receptor-T-cell therapy: implication for future therapies
    Sterner, Rosalie M.
    Kenderian, Saad S.
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (01) : 41 - 48
  • [50] Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT
    Li, Siqi
    Wang, Hongrong
    Wang, Guanyun
    Lu, Xia
    Yang, Jigang
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (05) : 445 - 447